Rallybio Corp financial data

Symbol
RLYB on Nasdaq
Location
New Haven, CT
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.23K % +27.3%
Debt-to-equity 8.91 % -23.3%
Return On Assets -23.2 % +66.6%
Operating Margin -6K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 42.2M shares +1.82%
Common Stock, Shares, Outstanding 41.9M shares +1.08%
Entity Public Float 36.7M USD -72.7%
Common Stock, Value, Issued 4K USD 0%
Weighted Average Number of Shares Outstanding, Basic 45.1M shares +1.04%
Weighted Average Number of Shares Outstanding, Diluted 45.1M shares +1.04%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 638K USD -29.1%
Research and Development Expense 23.3M USD -53.4%
General and Administrative Expense 15.6M USD -24.1%
Operating Income (Loss) -38.3M USD +45.3%
Nonoperating Income (Expense) 25.4M USD +366%
Net Income (Loss) Attributable to Parent -14.2M USD +78.8%
Earnings Per Share, Basic 0 USD/shares +81.3%
Earnings Per Share, Diluted 0 USD/shares +81.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 32.1M USD +26.9%
Marketable Securities, Current 27.2M USD -45.4%
Cash, Cash Equivalents, and Short-term Investments 59.3M USD -21%
Other Assets, Current 2.67M USD +52.3%
Assets, Current 66.6M USD -14.8%
Property, Plant and Equipment, Net 26K USD -82.1%
Operating Lease, Right-of-Use Asset 198K USD -1.49%
Other Assets, Noncurrent 810K USD
Assets 67.7M USD -14.4%
Accounts Payable, Current 269K USD -53.9%
Accrued Liabilities, Current 3.74M USD -40.5%
Contract with Customer, Liability, Current 424K USD -61.3%
Liabilities, Current 4.52M USD -44.8%
Contract with Customer, Liability, Noncurrent 0 USD
Operating Lease, Liability, Noncurrent 108K USD
Liabilities 4.63M USD -43.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 24K USD -85.8%
Retained Earnings (Accumulated Deficit) -296M USD -5.03%
Stockholders' Equity Attributable to Parent 63M USD -11%
Liabilities and Equity 67.7M USD -14.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.2M USD +34%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities 11.1M USD +7.96%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 41.9M shares +1.08%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 876K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 32.1M USD +26.9%
Deferred Tax Assets, Valuation Allowance 98M USD +25.2%
Deferred Tax Assets, Gross 98M USD +25.2%
Operating Lease, Liability 154K USD -60.7%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -14.3M USD +78.5%
Lessee, Operating Lease, Liability, to be Paid 156K USD -61.6%
Property, Plant and Equipment, Gross 769K USD 0%
Operating Lease, Liability, Current 90K USD -60.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 176K USD -23.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 156K USD -32.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2K USD -85.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards 46M USD +23.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Additional Paid in Capital 359M USD +1.85%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 6.5M USD -24.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%